Important disclaimerThis page is for educational purposes only and summarizes published research. H2CAP is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease, including cancer. Nothing on this page is medical advice. Always consult your oncologist or medical team before making any changes to your cancer care plan.

Hydrogen water and cancer is an active research topic. Scientists are studying a specific biochemical mechanism - the selective antioxidant activity of molecular hydrogen (H₂) - and what a still-limited number of peer-reviewed studies report about its relationship to oxidative stress in patients undergoing chemotherapy and radiation therapy. This page summarizes that published research. It is not a claim that hydrogen water treats, prevents, or cures cancer.

Definition Reactive oxygen species (ROS) - chemically reactive molecules containing oxygen, produced as a natural byproduct of cellular metabolism. In excess, ROS can damage DNA, proteins, and cell membranes. Cancer cells and cancer treatments both generate elevated levels of ROS - the hydroxyl radical (·OH) is considered the most reactive.

Cancer cells generate elevated levels of ROS as a byproduct of their accelerated metabolism. This oxidative environment is associated with tumor growth and can affect surrounding healthy tissue.

Chemotherapy and radiation therapy also generate significant ROS - by design in cancer cells, but also in healthy organs, which researchers associate with common side effects: fatigue, nausea, organ toxicity, and reduced quality of life. This is why researchers have looked at whether selective antioxidants might help manage treatment-related oxidative stress without interfering with treatment itself.

Why Is Molecular Hydrogen Being Studied Specifically?

Unlike broad-spectrum antioxidants (vitamin C, vitamin E) that suppress oxidative activity generally, molecular hydrogen is reported in laboratory studies to selectively neutralize specific reactive species - the hydroxyl radical (·OH) and peroxynitrite (ONOO⁻) - while leaving other ROS signaling intact.

The National Cancer Institute (NCI) dictionary entry describes hydrogen-rich water as having potential preventive, antioxidant, anti-inflammatory, and radiation-protective activities under investigation. This reflects ongoing scientific interest, not an approved medical use.

An important distinction: research does not suggest hydrogen protects cancer cells from treatmentMultiple studies report that H₂ does not reduce the cytotoxicity of chemotherapy or radiation against tumor cells in the models studied (Frontiers in Oncology, 2019).

What Mechanisms Are Being Studied?

The research rationale for studying hydrogen water and cancer involves several proposed mechanisms, documented in early-stage peer-reviewed literature:

① Selective ·OH Scavenging
Laboratory studies suggest H₂ neutralizes highly reactive free radicals in healthy tissue without measurably interfering with treatment-induced ROS in tumor cells.
② Anti-Inflammatory Signaling
Some studies report reduced pro-inflammatory cytokines (TNF-α, IL-6), which are associated with treatment side effects.
③ Cell-Level Research Findings
A subset of laboratory studies report H₂ effects on certain cancer cell lines - this is early-stage research, not a clinical finding in patients.
④ Immune-Related Research
Some research explores hydrogen's relationship to immune cell activity, an area still under active investigation.

A further proposed mechanism - Nrf2 pathway activation - involves upregulating the body's own antioxidant defense enzymes (SOD, HO-1) in healthy tissue. These mechanisms have been reported across a range of study designs, from laboratory models to a small number of randomized controlled trials in human cancer patients. The overall body of clinical evidence remains limited.

What Does the Kang et al. (2011) Trial Show?

Medical Gas Research · 2011 · PMC3231938 - Kang et al. ↗
Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumors

Study design: 49 patients with malignant liver tumors undergoing radiotherapy were randomized to drink either hydrogen-rich water (0.55-0.65 mM dissolved H₂) or placebo water for 6 weeks. Quality of life was assessed using the validated EORTC QLQ-C30 instrument. Oxidative stress markers - d-ROM and BAP - were measured throughout.

Results: The hydrogen-rich water group showed reduced reactive oxygen metabolites in the blood. Quality-of-life scores during radiotherapy were higher in the hydrogen group than placebo. There was no measured difference in tumor response to radiotherapy between groups.

QoL scores higherTumor response unchangedRCT · n=49 · placebo-controlled
On sample sizeThis trial involved 49 patients - a meaningful starting point, but too small to draw firm conclusions on its own. Larger, independently replicated trials would be needed before any clinical recommendation could be made.

What Do Chemotherapy-Related Studies Report?

Liver Markers During mFOLFOX6 Chemotherapy

Frontiers in Oncology · 2019 - Chen W et al. ↗
Hydrogen-rich water clinical study in colorectal cancer patients receiving mFOLFOX6 chemotherapy

This study examined 136 colorectal cancer patients receiving mFOLFOX6 chemotherapy, a regimen associated with liver-related side effects. The placebo group showed elevations in liver enzyme markers (ALT, AST, indirect bilirubin); the hydrogen-rich water group showed smaller changes in these markers during treatment.

Smaller liver enzyme changesn=136 · colorectal cancer

Laboratory Research on 5-FU Combination

A 2022 experimental study (World Journal of Gastroenterology, PMID:35116114) reported that in a colorectal cancer animal model, hydrogen-rich water combined with 5-fluorouracil (5-FU) was associated with reduced tumor weight and size compared to 5-FU alone, along with reduced markers of oxidative stress. This is an animal-model finding and has not been confirmed in human trials.

Cisplatin-Related Toxicity Research

Cisplatin is associated with significant oxidative stress, including kidney-related effects. A 2024 review (Biomedicines, MDPI) discusses laboratory and early clinical evidence that molecular hydrogen may reduce cisplatin-related oxidative stress markers without reducing cisplatin's anti-tumor activity in the models studied.

What Does the Broader Body of Evidence Show?

Asian Pacific Journal of Cancer Prevention · 2023 · PMID:36708550 - Mohd Noor et al. ↗
A Systematic Review of Molecular Hydrogen Therapy in Cancer Management

This review analyzed 27 eligible studies drawn from 677 identified across Cochrane, PubMed, and Google Scholar, spanning laboratory, animal, and human studies. The reviewers reported a consistent safety profile with no adverse effects identified across included studies, and noted trends across cancer types (liver, colorectal, lung, pancreatic, leukemia) that the authors describe as warranting further clinical investigation.

27 studies · 5 cancer typesNo adverse effects reportedSystematic review · 2023

A 2024 review in Journal of Cancer Research and Clinical Oncology (PMC10982102) discusses hydrogen's studied relationship to immune cell activity, including research on T-cell populations in colorectal cancer patients. As of 2023, more than 80 clinical trials on hydrogen therapy have been registered globally, indicating growing research interest - though a registered trial does not by itself establish clinical efficacy.

H2CAP Plus: Product Specifications

The studies summarized on this page used a range of hydrogen concentrations and protocols. The table below lists H2CAP Plus's rated output alongside concentrations reported in the research, for reference only. A comparable concentration does not mean a comparable clinical effect - hydrogen water has not been evaluated by regulatory authorities as a cancer treatment.

Reference PointConcentration StudiedH2CAP Plus Rated Output
Kang et al. 2011 (liver tumor RCT)550-650 ppb1,500 ppb
Colorectal cancer clinical studies1,000-1,500 ppb1,500 ppb
2023 systematic review (27 studies)Variable, generally <1,500 ppb1,500 ppb

What Is ORP and Why Is It Mentioned?

H2CAP hydrogen water is rated at approximately -800 mV oxidation-reduction potential, indicating antioxidant character. Ordinary tap water typically measures +200 to +400 mV. ORP is a water-chemistry measurement, not a clinical outcome measure.

What Technology Does H2CAP Plus Use?

H2CAP Plus uses platinum-coated titanium electrodes with Proton Exchange Membrane (PEM) / Solid Polymer Electrolyte (SPE) electrolysis, a method also used in hydrogen research equipment. The PEM membrane separates hydrogen from ozone and chlorine byproducts. H2CAP is certified by the Japan Hydrogen Products Association (JHPA), which independently verifies dissolved H₂ concentration and device performance.

Portable Hydrogen Water Generator
H2CAP Plus
Hydrogen Generator

JHPA-certified PEM/SPE technology. Rated up to 1,500 ppb dissolved H₂ in about 3.5 minutes. Attaches to any water bottle. Not a medical device.

Specifications
H₂ Output1,500 ppb
ORP−800 mV
Cycle Time~3.5 min
TechnologyPEM/SPE
CertificationJHPA ✓
ByproductsNone

General Considerations for Daily Use

H2CAP Plus is a consumer water-treatment product, not a prescribed therapy. Anyone considering hydrogen water alongside cancer treatment should discuss it with their oncology team first, including timing relative to treatment sessions and any interactions with medications.

How Is Dissolved Hydrogen Typically Consumed?

Published studies on hydrogen-rich water generally have participants drink it across the day rather than at a single sitting. Dissolved H₂ is a volatile gas and begins dissipating soon after it is generated, which is why hydrogen water is typically consumed shortly after generation rather than stored.

Consult your care team firstThis page describes general product information and published research, not a usage protocol for cancer patients. Timing, volume, and whether hydrogen water is appropriate at all should be discussed with your oncologist, particularly during active treatment.

What Else Is Relevant to Supportive Care?

Hydrogen water is one subject among many in supportive-care research. It is not a cure and not a replacement for oncology care. Other factors commonly discussed in supportive cancer care include:

  • Diet and nutrition, as advised by an oncology dietitian
  • Physical activity as tolerated and approved by a care team
  • Stress management and mental health support
  • Open, ongoing communication with the oncology team about any supportive measures being considered
Portable H₂
H2CAP Plus - 1,500 ppb Rated Output · JHPA Certified · 3.5 min
H₂ Science Guide
Molecular Hydrogen Health - Research Overview
Research Library
Hydrogen Water Studies - PubMed-Cited Papers

FAQ: Hydrogen Water and Cancer Research - 5 Questions Answered

Does hydrogen water protect cancer cells from chemotherapy or radiation?
No. Multiple studies, including a 2019 Frontiers in Oncology trial, report that H₂ does not reduce the cytotoxicity of chemotherapy or radiation against tumor cells in the models studied. This is a research finding, not a clinical guarantee.
What does the most-cited clinical study show about hydrogen water and cancer?
A randomized, placebo-controlled trial (Kang et al., 2011, Medical Gas Research, PMC3231938) gave 49 liver tumor patients undergoing radiotherapy either hydrogen-rich water (550-650 ppb H₂) or placebo for 6 weeks. The hydrogen group showed reduced oxidative stress markers and higher quality-of-life scores, with no measured difference in tumor response between groups. The sample size is modest.
Can hydrogen water reduce chemotherapy side effects?
Some published research points in that direction for specific toxicities. A Frontiers in Oncology study of 136 colorectal cancer patients on mFOLFOX6 chemotherapy found smaller liver enzyme changes in the hydrogen water group than the placebo group. These are research findings, not treatment recommendations - discuss any supportive measures with your oncology team.
What H₂ concentration does H2CAP Plus produce?
H2CAP Plus is rated to produce up to 1,500 ppb dissolved H₂ in about 3.5 minutes, independently verified through JHPA certification. This is a product specification. Output concentration alone does not establish that a product will reproduce results from any specific study.
Is hydrogen water a cancer treatment?
No. Hydrogen water is not a medical device and is not intended to diagnose, treat, cure, or prevent cancer. The research summarized on this page explores an active scientific question, not an established therapy. Always consult your oncologist before adding any supportive measure.